JOUNCE THERAPEUTICS INC (JNCE)       1.21  0 (0%)

1.21  0 (0%)

US4811161011 - Common Stock - After market: 1.21 0 (0%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.0026.91M62.30M147.90M65.20M
Operating Expenses
132.86M117.96M107.50M95.10M96.50M
Income Before Taxes
-132.09M-90.86M-43.80M56.90M-27.30M
Income Tax
24.00K15.00K0.000.000.00
Net Income
-132.11M-90.87M-43.80M56.80M-27.40M
 
Per Share Data
EPS Diluted Total Ops
-2.56-1.82-1.241.66-0.84
Non GAAP EPS
-2.56-1.84-1.471.63-0.83
 
Statistics
Profit Margin
N/A-337.73%-70.30%38.40%-42.02%

All data in USD

Charts